The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
about
Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexesCharacterization of magnesium requirement of human 5'-tyrosyl DNA phosphodiesterase mediated reactionAnalysis of the Active-Site Mechanism of Tyrosyl-DNA Phosphodiesterase I: A Member of the Phospholipase D SuperfamilyTyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform.Biochemical assays for the discovery of TDP1 inhibitorsNeuroprotection and repair of 3'-blocking DNA ends by glaikit (gkt) encoding Drosophila tyrosyl-DNA phosphodiesterase 1 (TDP1).Effects of DNA and protein size on substrate cleavage by human tyrosyl-DNA phosphodiesterase 1.Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitorsTyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs.Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panelPARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage.TDP1 is critical for the repair of DNA breaks induced by sapacitabine, a nucleoside also targeting ATM- and BRCA-deficient tumors.SUMO modification of the neuroprotective protein TDP1 facilitates chromosomal single-strand break repair.TDP1 promotes assembly of non-homologous end joining protein complexes on DNA.Tyrosyl-DNA phosphodiesterase 1 initiates repair of apurinic/apyrimidinic sites.Structural basis for DNA 3'-end processing by human tyrosyl-DNA phosphodiesterase 1.Reactive oxygen species stress increases accumulation of tyrosyl-DNA phsosphodiesterase 1 within mitochondria.Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy
P2860
Q24294083-F206D7AD-1072-46E8-B5A7-1CC2150AAF21Q24307037-4F9897C9-1B2E-42CE-8748-53B56089CF94Q27676072-B660C3B6-7772-4151-8538-E11BC762E52EQ33875792-400E9C55-4950-4266-80C4-7DD6B55A8152Q34017010-462BD820-4ED8-463C-90E7-94BA3AF33589Q34021070-E152B4F5-0B4B-44EE-ADBD-D0008653511DQ34480920-5143077A-F1D9-435F-AC3E-398561C93B4DQ35152316-CE8A2D57-FC9D-4A77-9C97-1C8F6B4AF68FQ35167579-669B65A1-BAAE-4AA6-A7A4-73B691042999Q35921514-DAF61997-6990-450E-B68F-DBCBAB3FF0F8Q37148469-9BC57339-A38C-4CCC-B2AA-4BDFB4B88C1BQ37572609-944B5E01-5B42-4D2E-B0C1-6DB7281223A6Q37701295-21075E24-FFEC-4420-BAF0-4E9338CBE4BDQ38695053-29EA52B8-205C-4F19-A786-0F262EC88657Q39380131-F14D050A-ECD6-4171-8178-F85A20CCEC4AQ41116917-49A16ADF-74B0-4650-8851-A45F22CCF736Q42022533-57AB691D-B48D-4CA4-9CF9-D042AA9D1F15Q47236725-85630185-1E1D-43D2-9C44-B44646E16704Q52361042-24D277A0-F1FC-46A6-A67D-AC55CE8AECE3Q58759037-5E85F402-91C6-48FF-86F0-5740AF249C59
P2860
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@ast
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@en
type
label
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@ast
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@en
prefLabel
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@ast
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@en
P2093
P2860
P356
P1476
The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
@en
P2093
Andrew G Stephen
Matthew J Fivash
Robert J Fisher
Thomas S Dexheimer
P2860
P304
P356
10.1093/NAR/GKP1206
P407
P50
P577
2010-01-21T00:00:00Z